CovidChloroV1, Main, Exploration, bibRecord, 000B85

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.

Identifieur interne : 000B85 ( Main/Exploration ); précédent : 000B84; suivant : 000B86

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.

Auteurs : Sebastian E. Sattui [États-Unis] ; Jean W. Liew [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Ariella Coler-Reilly [États-Unis] ; Francis Berenbaum [France] ; Alí Duarte-García [États-Unis] ; Carly Harrison [États-Unis] ; Maximilian F. Konig [États-Unis] ; Peter Korsten [Allemagne] ; Michael S. Putman [États-Unis] ; Philip C. Robinson [Australie] ; Emily Sirotich [Canada] ; Manuel F. Ugarte-Gil [Pérou] ; Kate Webb [Afrique du Sud, Royaume-Uni] ; Kristen J. Young [États-Unis] ; Alfred H J. Kim [États-Unis] ; Jeffrey A. Sparks [États-Unis]

Source :

Expert review of clinical immunology [ 1744-8409 ] ; 2020.

RBID : pubmed:32620062

Descripteurs français

KwdFr :
- Antiviraux (usage thérapeutique), Betacoronavirus (effets des médicaments et des substances chimiques), Communication (MeSH), Humains (MeSH), Hydroxychloroquine (usage thérapeutique), Infections à coronavirus (traitement médicamenteux), Opinion publique (MeSH), Pandémies (MeSH), Pneumopathie virale (traitement médicamenteux), Résultat thérapeutique (MeSH).
MESH :
- effets des médicaments et des substances chimiques : Betacoronavirus.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Antiviraux, Hydroxychloroquine.
- Communication, Humains, Opinion publique, Pandémies, Résultat thérapeutique.

English descriptors

KwdEn :
- Antiviral Agents (therapeutic use), Betacoronavirus (drug effects), COVID-19 (MeSH), Communication (MeSH), Coronavirus Infections (drug therapy), Humans (MeSH), Hydroxychloroquine (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Public Opinion (MeSH), SARS-CoV-2 (MeSH), Treatment Outcome (MeSH).
MESH :
- chemical , therapeutic use : Antiviral Agents, Hydroxychloroquine.
- drug effects : Betacoronavirus.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- COVID-19, Communication, Humans, Pandemics, Public Opinion, SARS-CoV-2, Treatment Outcome.

Abstract

INTRODUCTION

Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications. In particular, the off-label use of hydroxychloroquine for COVID-19 prophylaxis and treatment has created many unprecedented challenges for the scientific community and the public.

AREAS COVERED

We critically assessed major events from February - May 2020 that contributed to widespread use of hydroxychloroquine for the treatment and prophylaxis of COVID-19. We aimed to explore how opinions toward hydroxychloroquine may shift from early enthusiasm (based on

EXPERT OPINION

Mindful and rigorous acquisition of data, as well as its interpretation, are essential to an effective pandemic response. The rapid and premature promotion of results has had major implications for global crisis management, even creating distrust among the public. It is crucial for the medical and scientific community to incorporate the lessons learned from this situation.

DOI: 10.1080/1744666X.2020.1792778
PubMed: 32620062
PubMed Central: PMC7594186

Affiliations:

Afrique du Sud, Allemagne, Australie, Canada, France, Pérou, Royaume-Uni, États-Unis
Angleterre, Basse-Saxe, Grand Londres, Illinois, Maryland, Massachusetts, Minnesota, Missouri (État), Texas, Washington (État), État de New York, Île-de-France
Göttingen, Londres, Paris

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001240
to stream Main, to step Curation: 001240

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.</title>
<author><name sortKey="Sattui, Sebastian E" sort="Sattui, Sebastian E" uniqKey="Sattui S" first="Sebastian E" last="Sattui">Sebastian E. Sattui</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, Hospital for Special Surgery , New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, Hospital for Special Surgery , New York, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of Washington , Seattle, WA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, University of Washington , Seattle, WA</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Coler Reilly, Ariella" sort="Coler Reilly, Ariella" uniqKey="Coler Reilly A" first="Ariella" last="Coler-Reilly">Ariella Coler-Reilly</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Berenbaum, Francis" sort="Berenbaum, Francis" uniqKey="Berenbaum F" first="Francis" last="Berenbaum">Francis Berenbaum</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, Sorbonne University, INSERM CRSA, AP-HP , Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Sorbonne University, INSERM CRSA, AP-HP , Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Duarte Garcia, Ali" sort="Duarte Garcia, Ali" uniqKey="Duarte Garcia A" first="Alí" last="Duarte-García">Alí Duarte-García</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Mayo Clinic , Rochester, MN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Mayo Clinic , Rochester, MN</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Harrison, Carly" sort="Harrison, Carly" uniqKey="Harrison C" first="Carly" last="Harrison">Carly Harrison</name>
<affiliation wicri:level="2"><nlm:affiliation>LupusChat , New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>LupusChat , New York, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Korsten, Peter" sort="Korsten, Peter" uniqKey="Korsten P" first="Peter" last="Korsten">Peter Korsten</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen , Göttingen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Nephrology and Rheumatology, University Medical Center Göttingen , Göttingen</wicri:regionArea>
<placeName><region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Putman, Michael S" sort="Putman, Michael S" uniqKey="Putman M" first="Michael S" last="Putman">Michael S. Putman</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Northwestern University , Chicago, IL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Northwestern University , Chicago, IL</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Queensland Faculty of Medicine , Brisbane, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland Faculty of Medicine , Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sirotich, Emily" sort="Sirotich, Emily" uniqKey="Sirotich E" first="Emily" last="Sirotich">Emily Sirotich</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Canadian Arthritis Patient Alliance , Toronto, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Canadian Arthritis Patient Alliance , Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ugarte Gil, Manuel F" sort="Ugarte Gil, Manuel F" uniqKey="Ugarte Gil M" first="Manuel F" last="Ugarte-Gil">Manuel F. Ugarte-Gil</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Universidad Científica Del Sur and Hospital Nacional Guillermo Almenara Irigoyen , EsSalud, Lima, Peru.</nlm:affiliation>
<country xml:lang="fr">Pérou</country>
<wicri:regionArea>School of Medicine, Universidad Científica Del Sur and Hospital Nacional Guillermo Almenara Irigoyen , EsSalud, Lima</wicri:regionArea>
<wicri:noRegion>Lima</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Webb, Kate" sort="Webb, Kate" uniqKey="Webb K" first="Kate" last="Webb">Kate Webb</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Paediatric Rheumatology, University of Cape Town , Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Paediatric Rheumatology, University of Cape Town , Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Francis Crick Institute , London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Francis Crick Institute , London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Young, Kristen J" sort="Young, Kristen J" uniqKey="Young K" first="Kristen J" last="Young">Kristen J. Young</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatic Diseases, UT Southwestern Medical Center , Dallas, TX, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatic Diseases, UT Southwestern Medical Center , Dallas, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kim, Alfred H J" sort="Kim, Alfred H J" uniqKey="Kim A" first="Alfred H J" last="Kim">Alfred H J. Kim</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , Saint Louis, MO, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , Saint Louis, MO</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32620062</idno>
<idno type="pmid">32620062</idno>
<idno type="doi">10.1080/1744666X.2020.1792778</idno>
<idno type="pmc">PMC7594186</idno>
<idno type="wicri:Area/Main/Corpus">001240</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001240</idno>
<idno type="wicri:Area/Main/Curation">001240</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001240</idno>
<idno type="wicri:Area/Main/Exploration">001240</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.</title>
<author><name sortKey="Sattui, Sebastian E" sort="Sattui, Sebastian E" uniqKey="Sattui S" first="Sebastian E" last="Sattui">Sebastian E. Sattui</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, Hospital for Special Surgery , New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, Hospital for Special Surgery , New York, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of Washington , Seattle, WA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, University of Washington , Seattle, WA</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Coler Reilly, Ariella" sort="Coler Reilly, Ariella" uniqKey="Coler Reilly A" first="Ariella" last="Coler-Reilly">Ariella Coler-Reilly</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Berenbaum, Francis" sort="Berenbaum, Francis" uniqKey="Berenbaum F" first="Francis" last="Berenbaum">Francis Berenbaum</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, Sorbonne University, INSERM CRSA, AP-HP , Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Sorbonne University, INSERM CRSA, AP-HP , Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Duarte Garcia, Ali" sort="Duarte Garcia, Ali" uniqKey="Duarte Garcia A" first="Alí" last="Duarte-García">Alí Duarte-García</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Mayo Clinic , Rochester, MN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Mayo Clinic , Rochester, MN</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Harrison, Carly" sort="Harrison, Carly" uniqKey="Harrison C" first="Carly" last="Harrison">Carly Harrison</name>
<affiliation wicri:level="2"><nlm:affiliation>LupusChat , New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>LupusChat , New York, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Korsten, Peter" sort="Korsten, Peter" uniqKey="Korsten P" first="Peter" last="Korsten">Peter Korsten</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen , Göttingen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Nephrology and Rheumatology, University Medical Center Göttingen , Göttingen</wicri:regionArea>
<placeName><region type="land" nuts="2">Basse-Saxe</region>
<settlement type="city">Göttingen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Putman, Michael S" sort="Putman, Michael S" uniqKey="Putman M" first="Michael S" last="Putman">Michael S. Putman</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Northwestern University , Chicago, IL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Northwestern University , Chicago, IL</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Queensland Faculty of Medicine , Brisbane, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland Faculty of Medicine , Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sirotich, Emily" sort="Sirotich, Emily" uniqKey="Sirotich E" first="Emily" last="Sirotich">Emily Sirotich</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Canadian Arthritis Patient Alliance , Toronto, ON, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Canadian Arthritis Patient Alliance , Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ugarte Gil, Manuel F" sort="Ugarte Gil, Manuel F" uniqKey="Ugarte Gil M" first="Manuel F" last="Ugarte-Gil">Manuel F. Ugarte-Gil</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Universidad Científica Del Sur and Hospital Nacional Guillermo Almenara Irigoyen , EsSalud, Lima, Peru.</nlm:affiliation>
<country xml:lang="fr">Pérou</country>
<wicri:regionArea>School of Medicine, Universidad Científica Del Sur and Hospital Nacional Guillermo Almenara Irigoyen , EsSalud, Lima</wicri:regionArea>
<wicri:noRegion>Lima</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Webb, Kate" sort="Webb, Kate" uniqKey="Webb K" first="Kate" last="Webb">Kate Webb</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Paediatric Rheumatology, University of Cape Town , Cape Town, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Department of Paediatric Rheumatology, University of Cape Town , Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Francis Crick Institute , London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Francis Crick Institute , London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Young, Kristen J" sort="Young, Kristen J" uniqKey="Young K" first="Kristen J" last="Young">Kristen J. Young</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatic Diseases, UT Southwestern Medical Center , Dallas, TX, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatic Diseases, UT Southwestern Medical Center , Dallas, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kim, Alfred H J" sort="Kim, Alfred H J" uniqKey="Kim A" first="Alfred H J" last="Kim">Alfred H J. Kim</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , Saint Louis, MO, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , Saint Louis, MO</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Expert review of clinical immunology</title>
<idno type="eISSN">1744-8409</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (drug effects)</term>
<term>COVID-19 (MeSH)</term>
<term>Communication (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Public Opinion (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (usage thérapeutique)</term>
<term>Betacoronavirus (effets des médicaments et des substances chimiques)</term>
<term>Communication (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Opinion publique (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Résultat thérapeutique (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Communication</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Public Opinion</term>
<term>SARS-CoV-2</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Communication</term>
<term>Humains</term>
<term>Opinion publique</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b>
</p>
<p>Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications. In particular, the off-label use of hydroxychloroquine for COVID-19 prophylaxis and treatment has created many unprecedented challenges for the scientific community and the public.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>AREAS COVERED</b>
</p>
<p>We critically assessed major events from February - May 2020 that contributed to widespread use of hydroxychloroquine for the treatment and prophylaxis of COVID-19. We aimed to explore how opinions toward hydroxychloroquine may shift from early enthusiasm (based on </p>
</div>
<div type="abstract" xml:lang="en"><p><b>EXPERT OPINION</b>
</p>
<p>Mindful and rigorous acquisition of data, as well as its interpretation, are essential to an effective pandemic response. The rapid and premature promotion of results has had major implications for global crisis management, even creating distrust among the public. It is crucial for the medical and scientific community to incorporate the lessons learned from this situation.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32620062</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>05</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8409</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16</Volume>
<Issue>7</Issue>
<PubDate><Year>2020</Year>
<Month>07</Month>
</PubDate>
</JournalIssue>
<Title>Expert review of clinical immunology</Title>
<ISOAbbreviation>Expert Rev Clin Immunol</ISOAbbreviation>
</Journal>
<ArticleTitle>Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>659-666</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/1744666X.2020.1792778</ELocationID>
<Abstract><AbstractText Label="INTRODUCTION">Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications. In particular, the off-label use of hydroxychloroquine for COVID-19 prophylaxis and treatment has created many unprecedented challenges for the scientific community and the public.</AbstractText>
<AbstractText Label="AREAS COVERED">We critically assessed major events from February - May 2020 that contributed to widespread use of hydroxychloroquine for the treatment and prophylaxis of COVID-19. We aimed to explore how opinions toward hydroxychloroquine may shift from early enthusiasm (based on <i>in vitro</i>
 and preliminary clinical data) to the hope for a miracle cure (through communication and promotion of questionable results) and, finally, to a rise of skepticism as more in-depth analyses are emerging.</AbstractText>
<AbstractText Label="EXPERT OPINION">Mindful and rigorous acquisition of data, as well as its interpretation, are essential to an effective pandemic response. The rapid and premature promotion of results has had major implications for global crisis management, even creating distrust among the public. It is crucial for the medical and scientific community to incorporate the lessons learned from this situation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sattui</LastName>
<ForeName>Sebastian E</ForeName>
<Initials>SE</Initials>
<Identifier Source="ORCID">0000-0002-3945-6828</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Hospital for Special Surgery , New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liew</LastName>
<ForeName>Jean W</ForeName>
<Initials>JW</Initials>
<Identifier Source="ORCID">0000-0002-8104-2450</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Washington , Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Graef</LastName>
<ForeName>Elizabeth R</ForeName>
<Initials>ER</Initials>
<Identifier Source="ORCID">0000-0001-5973-3477</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Coler-Reilly</LastName>
<ForeName>Ariella</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">0000-0001-8549-6559</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berenbaum</LastName>
<ForeName>Francis</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">0000-0001-8252-7815</Identifier>
<AffiliationInfo><Affiliation>Department of Rheumatology, Sorbonne University, INSERM CRSA, AP-HP , Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Duarte-García</LastName>
<ForeName>Alí</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">0000-0003-1749-5719</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Mayo Clinic , Rochester, MN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Harrison</LastName>
<ForeName>Carly</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">0000-0001-6291-587X</Identifier>
<AffiliationInfo><Affiliation>LupusChat , New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Konig</LastName>
<ForeName>Maximilian F</ForeName>
<Initials>MF</Initials>
<Identifier Source="ORCID">0000-0001-5045-5255</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Korsten</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">0000-0001-6065-5680</Identifier>
<AffiliationInfo><Affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen , Göttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Putman</LastName>
<ForeName>Michael S</ForeName>
<Initials>MS</Initials>
<Identifier Source="ORCID">0000-0001-9699-4000</Identifier>
<AffiliationInfo><Affiliation>Department of Medicine, Northwestern University , Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Robinson</LastName>
<ForeName>Philip C</ForeName>
<Initials>PC</Initials>
<Identifier Source="ORCID">0000-0002-3156-3418</Identifier>
<AffiliationInfo><Affiliation>University of Queensland Faculty of Medicine , Brisbane, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sirotich</LastName>
<ForeName>Emily</ForeName>
<Initials>E</Initials>
<Identifier Source="ORCID">0000-0002-7087-8543</Identifier>
<AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Canadian Arthritis Patient Alliance , Toronto, ON, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ugarte-Gil</LastName>
<ForeName>Manuel F</ForeName>
<Initials>MF</Initials>
<Identifier Source="ORCID">0000-0003-1728-1999</Identifier>
<AffiliationInfo><Affiliation>School of Medicine, Universidad Científica Del Sur and Hospital Nacional Guillermo Almenara Irigoyen , EsSalud, Lima, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Webb</LastName>
<ForeName>Kate</ForeName>
<Initials>K</Initials>
<Identifier Source="ORCID">0000-0003-1087-5946</Identifier>
<AffiliationInfo><Affiliation>Department of Paediatric Rheumatology, University of Cape Town , Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Francis Crick Institute , London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Young</LastName>
<ForeName>Kristen J</ForeName>
<Initials>KJ</Initials>
<Identifier Source="ORCID">0000-0001-8570-2228</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatic Diseases, UT Southwestern Medical Center , Dallas, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Alfred H J</ForeName>
<Initials>AHJ</Initials>
<Identifier Source="ORCID">0000-0003-4074-0516</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine , Saint Louis, MO, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sparks</LastName>
<ForeName>Jeffrey A</ForeName>
<Initials>JA</Initials>
<Identifier Source="ORCID">0000-0002-5556-4618</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>P30 AR073752</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>T32 AR048522</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>K23 AR069688</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R03 AR075886</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P30 AR072579</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>L30 AR066953</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Expert Rev Clin Immunol</MedlineTA>
<NlmUniqueID>101271248</NlmUniqueID>
<ISSNLinking>1744-666X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011639" MajorTopicYN="Y">Public Opinion</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="Y">antimalarials</Keyword>
<Keyword MajorTopicYN="Y">chloroquine</Keyword>
<Keyword MajorTopicYN="Y">coronavirus disease 2019</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32620062</ArticleId>
<ArticleId IdType="doi">10.1080/1744666X.2020.1792778</ArticleId>
<ArticleId IdType="pmc">PMC7594186</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):734-736</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32295786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 May 14;369:m1849</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1425-1433</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32407884</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Oct;79(10):1386-1388</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32381561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32347743</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Cardiol. 2020 Sep 1;5(9):1067-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32936266</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Netw Open. 2020 Apr 24;3(4):e208857</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32330277</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med (N Y). 2020 Dec 18;1(1):114-127.e3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32838355</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 22;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32450107</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Cardiol. 2020 Sep 1;5(9):1036-1041</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32936252</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2020 May 1;368(6490):476-477</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32327600</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drugs. 2017 Dec;77(18):1935-1966</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29143192</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101663</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32289548</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 May 19;323(19):1897-1898</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32208486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 May 14;369:m1844</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 May;2(5):e250-e253</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32309814</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Jun 23;323(24):2493-2502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32392282</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Jun 16;172(12):819-821</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32227189</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Jun 2;172(11):754-755</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32232419</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 25;382(26):2582</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32501665</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):837-839</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32332072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105923</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32070753</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):e61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32295787</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Mar 23;368:m1166</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205321</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Jun 13;395(10240):1820</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32511943</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Afrique du Sud</li>
<li>Allemagne</li>
<li>Australie</li>
<li>Canada</li>
<li>France</li>
<li>Pérou</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Basse-Saxe</li>
<li>Grand Londres</li>
<li>Illinois</li>
<li>Maryland</li>
<li>Massachusetts</li>
<li>Minnesota</li>
<li>Missouri (État)</li>
<li>Texas</li>
<li>Washington (État)</li>
<li>État de New York</li>
<li>Île-de-France</li>
</region>
<settlement><li>Göttingen</li>
<li>Londres</li>
<li>Paris</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="État de New York"><name sortKey="Sattui, Sebastian E" sort="Sattui, Sebastian E" uniqKey="Sattui S" first="Sebastian E" last="Sattui">Sebastian E. Sattui</name>
</region>
<name sortKey="Coler Reilly, Ariella" sort="Coler Reilly, Ariella" uniqKey="Coler Reilly A" first="Ariella" last="Coler-Reilly">Ariella Coler-Reilly</name>
<name sortKey="Duarte Garcia, Ali" sort="Duarte Garcia, Ali" uniqKey="Duarte Garcia A" first="Alí" last="Duarte-García">Alí Duarte-García</name>
<name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name>
<name sortKey="Harrison, Carly" sort="Harrison, Carly" uniqKey="Harrison C" first="Carly" last="Harrison">Carly Harrison</name>
<name sortKey="Kim, Alfred H J" sort="Kim, Alfred H J" uniqKey="Kim A" first="Alfred H J" last="Kim">Alfred H J. Kim</name>
<name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name>
<name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name>
<name sortKey="Putman, Michael S" sort="Putman, Michael S" uniqKey="Putman M" first="Michael S" last="Putman">Michael S. Putman</name>
<name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name>
<name sortKey="Young, Kristen J" sort="Young, Kristen J" uniqKey="Young K" first="Kristen J" last="Young">Kristen J. Young</name>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Berenbaum, Francis" sort="Berenbaum, Francis" uniqKey="Berenbaum F" first="Francis" last="Berenbaum">Francis Berenbaum</name>
</region>
</country>
<country name="Allemagne"><region name="Basse-Saxe"><name sortKey="Korsten, Peter" sort="Korsten, Peter" uniqKey="Korsten P" first="Peter" last="Korsten">Peter Korsten</name>
</region>
</country>
<country name="Australie"><noRegion><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name>
</noRegion>
</country>
<country name="Canada"><noRegion><name sortKey="Sirotich, Emily" sort="Sirotich, Emily" uniqKey="Sirotich E" first="Emily" last="Sirotich">Emily Sirotich</name>
</noRegion>
<name sortKey="Sirotich, Emily" sort="Sirotich, Emily" uniqKey="Sirotich E" first="Emily" last="Sirotich">Emily Sirotich</name>
</country>
<country name="Pérou"><noRegion><name sortKey="Ugarte Gil, Manuel F" sort="Ugarte Gil, Manuel F" uniqKey="Ugarte Gil M" first="Manuel F" last="Ugarte-Gil">Manuel F. Ugarte-Gil</name>
</noRegion>
</country>
<country name="Afrique du Sud"><noRegion><name sortKey="Webb, Kate" sort="Webb, Kate" uniqKey="Webb K" first="Kate" last="Webb">Kate Webb</name>
</noRegion>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Webb, Kate" sort="Webb, Kate" uniqKey="Webb K" first="Kate" last="Webb">Kate Webb</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B85 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B85 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32620062
   |texte=   Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32620062" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki